Mindfulness Meditation for Insomnia

Last updated: February 24, 2026
Sponsor: Brigham and Women's Hospital
Overall Status: Active - Recruiting

Phase

1/2

Condition

Insomnia

Treatment

Uninstructed app-guided mindfulness meditation

Instructed bedtime app-guided mindfulness meditation

Sleep hygiene education

Clinical Study ID

NCT06972303
2025P001314
1K23AT012475
  • Ages > 18
  • All Genders

Study Summary

The investigators will conduct a 3-arm, pilot RCT where participants (N=30) will be randomized in a 1:1:1 design to 4 weeks of instructed bedtime MM practice at night (n=10) vs. uninstructed MM (n=10) vs. sleep hygiene education only (n=10). Aim 1 is to understand the feasibility and acceptability of the intervention and study procedures. Aim 2 is to explore patterns of within-group changes in sleep outcomes (i.e., insomnia severity and sleep quality). Patient-reported outcomes will be collected using a HIPAA-compliant electronic data management system (REDCap). Following informed consent, participants will receive links to REDCap surveys via email at Weeks 0, 4, 8, and 16. The investigators will also conduct a post-intervention interview at the end of Week 4 and an exit interview at Week 16. All participants will also receive a research kit with wearable devices and meet with our staff after they receive the kit for instructions. Data collected in the pilot RCT will help us to preliminarily identify tools for subjective measures and physiological signals to inform a future trial.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age 18 years and older;

  • Chronic insomnia (≥ 3 nights/week, for ≥ 3 months), defined by DSM-V or ICSD-3;

  • Have a primary complaint of difficulty falling asleep (sleep-onset insomnia) withself-reported sleep onset latency >20 min;

  • Insomnia Severity Index score ≥ 15;

  • Speak and understand English;

  • Have a smart device (phone or tablet) for mobile app installation

Exclusion

Exclusion Criteria:

  • Current diagnosis of sleep disorders other than insomnia (e.g., narcolepsy, restlessleg syndrome, REM sleep behavior disorder, etc.);

  • Shift worker or routine night shifts;

  • Women with pregnancy or breastfeeding;

  • Regular (defined as twice a week or more) practice of mind-body interventions;

  • Patients with pace-maker or routinely using cardiovascular medications that haveeffects on heart rates (i.e., beta-blockers);

  • Neurological disorders (e.g. epilepsy, dementia, stroke, Parkinson's disease,neuroinfections, brain tumors, etc.) or current diagnosis of comorbid psychotic,substance use, and trauma-related disorders;

  • Currently under medications with sleep changing effects (e.g.,anxiolytics/benzodiazepines, selective serotonin reuptake inhibitors, hypnotics,etc.);

  • Hearing impairment or loss. Participants will be asked to report any medication forat least 2 weeks prior to study onset and during the study period.

Study Design

Total Participants: 30
Treatment Group(s): 3
Primary Treatment: Uninstructed app-guided mindfulness meditation
Phase: 1/2
Study Start date:
February 01, 2026
Estimated Completion Date:
December 29, 2028

Connect with a study center

  • Brigham and Women's Hospital

    Boston 4930956, Massachusetts 6254926 02215
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.